Trials / Conditions / Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

16 registered clinical trials studyying Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cann NCT07441681	NRG Oncology	Phase 3
Recruiting	Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Ca NCT07195734	National Cancer Institute (NCI)	Phase 2
Not Yet Recruiting	Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Orophar NCT07178301	Northwestern University	Phase 2
Recruiting	Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy f NCT06532279	NRG Oncology	Phase 2
Recruiting	Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluati NCT06914999	Emory University	EARLY_Phase 1
Recruiting	Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer NCT06323460	Ohio State University Comprehensive Cancer Center	Phase 2
Recruiting	De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA NCT05541016	Mayo Clinic	Phase 2
Unknown	Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With T NCT04920344	Rutgers, The State University of New Jersey	Phase 2
Recruiting	Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Stud NCT04900623	Jonathan Schoenfeld, MD, MPH	Phase 2
Withdrawn	Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer NCT04140513	Ohio State University Comprehensive Cancer Center	N/A
Completed	Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unkn NCT04489212	Mayo Clinic	N/A
Active Not Recruiting	De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patien NCT03952585	National Cancer Institute (NCI)	Phase 2 / Phase 3
Active Not Recruiting	Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer NCT03811015	National Cancer Institute (NCI)	Phase 3
Active Not Recruiting	Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squ NCT03799445	M.D. Anderson Cancer Center	Phase 2
Terminated	Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Par NCT03618134	Jonsson Comprehensive Cancer Center	Phase 1 / Phase 2
Recruiting	Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With NCT03010150	M.D. Anderson Cancer Center	—